January 31, 2025 | Basel, Switzerland
Media release: English (PDF 0.4 MB) | Deutsch (PDF 0.4 MB)
Condensed financial report (PDF 0.5 MB)
Watch the webcast
Download the podcast (MP3 30 MB)
Download the presentation (PDF 4.7 MB)
Read the transcript
Novartis Q4 2024 impact and sustainability update (PDF 1.0 MB)
Basel, Switzerland
Watch the webcast
14:00 CEST | 13:00 BST | 08:00 EDT
Las Vegas, USA
Toronto, Canada
Frankfurt, Germany
New York, USA
New York, USA
Miami, USA
Interlaken, Switzerland
London, UK
London, UK
Basel, Switzerland
Basel, Switzerland
March 20, 2025
Zurich, Switzerland
March 12, 2025
Miami, USA
March 07, 2025
Basel, Switzerland
March 04, 2025
Boston, USA
March 04, 2025
London, UK
January 14, 2025
San Francisco, USA
Novartis CEO Vas Narasimhan presented at the J.P. Morgan Healthcare Conference.
December 09, 2024
Virtual event
Novartis 11th annual ESG investor event
December 04, 2024
Miami, USA
November 13, 2024
London, UK
November 12, 2024
Ranchos Palo Verdes, USA
November 12, 2024
Boston, USA
November 08, 2024
Zurich, Switzerland
October 28, 2024
Virtual
September 26, 2024
Munich, Germany
September 25, 2024
Paris, France
September 18, 2024
London, UK
September 05, 2024
New York, USA
June 27, 2024
Lyon, France
June 20, 2024
London, UK
June 19, 2024
London, UK
June 11, 2024
Miami, USA
June 06, 2024
New York, USA
May 29, 2024
New York, USA
May 23, 2024
Frankfurt, Germany
May 21, 2024
New York, USA
May 20, 2024
Brooklyn, USA
May 15, 2024
Toronto, Canada
May 15, 2024
Las Vegas, USA
March 26, 2024
Virtual
March 26, 2024
Paris, France
March 21, 2024
Zurich, Switzerland
March 06, 2024
Boston, USA
March 05, 2024
Basel, Switzerland
February 28, 2024
London, UK
January 08, 2024
San Francisco, USA
Download the presentation (PDF 1.3 MB)
November 28, 2023
London, UK
November 15, 2023
London, UK
November 08, 2023
Miami, USA
October 24, 2023
Basel, Switzerland
October 10, 2023
September 15, 2023
Basel, Switzerland
Sep 13, 2023
London, UK
Sep 12, 2023
New York, USA
September 06, 2023
Boston, USA
July 18, 2023
Basel, Switzerland
Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Condensed financial report (PDF 0.5 MB)
Download the interactive presentation (PDF 3.4 MB)
Download the podcast (MP3 34 MB)
Read the presentation transcript
Novartis Q2 2023 Impact and Sustainability Update (PDF 0.3 MB)
June 29, 2023
Bordeaux, France
June 22, 2023
London, UK
June 21, 2023
London, UK
June 12, 2023
Dana Point, USA
June 08, 2023
New York, USA
June 12, 2023
London, UK
May 09, 2023
Las Vegas, USA
April 26, 2023
Today Novartis has published updated 2022 quarterly and full year segment financials reflecting transfers of Sandoz biotechnology manufacturing services to other companies’ activities and the Coartem® brand from Sandoz to the Innovative Medicines Division, which were effective as of January 1, 2023. The 2022 updated segment financial reporting is provided in accordance with requirements of IFRS, and to aid comparability of 2023 quarterly and full year results for the segments and Corporate.
April 25, 2023
Basel, Switzerland
Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Condensed financial report (PDF 0.3 MB)
Download the interactive presentation (PDF 3.4 MB)
Download the podcast (MP3 34 MB)
Read the presentation transcript
Novartis Q1 2023 Impact and Sustainability Update (PDF 1.9 MB)
March 14, 2023
Miami, USA
March 07, 2023
Basel, Switzerland
March 07, 2023
Boston, USA
March 01, 2023
London, UK
February 21, 2023
Virtual
February 14, 2023
Virtual
February 08, 2023
Virtual
January 09, 2023
San Francisco, USA
Download the presentation (PDF 2.7 MB)
Download the podcast (MP3 18 MB)
December 13, 2022
Basel, Switzerland
Download the presentation (PDF 0.9 MB)
December 07, 2022
London, UK
December 01, 2022
Paris, France
November 16, 2022
London, UK
November 09-10, 2022
Palos Verdes, USA
November 09, 2022
London, UK
October 25, 2022
Basel, Switzerland
Media release:
English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB) | Français (PDF 0.3 MB)
Interim financial report (PDF 0.5 MB)
Download the presentation (PDF 3.7 MB)
Download the podcast (MP3 40 MB)
September 28, 2022
London, UK
September 21-22, 2022
Basel, Switzerland
Download the agenda (PDF 0.2 MB)
Download the interactive presentation (PDF 4.7 MB)
September 14, 2022
London, UK
September 12, 2022
New York, USA
August 25, 2022
Basel, Switzerland
Download the podcast (MP3 28 MB)
June 23, 2022
London, UK
June 15, 2022
London, UK
June 14, 2022
Palos Verdes, USA
June 10, 2022
New York, USA
June 09, 2022
New York, USA
June 02, 2022
New York, USA
May 23-24, 2022
New York, USA
May 23, 2022
New York, USA
May 18, 2022
New York, USA
May 18, 2022
Virtual
May 11, 2022
Paris, France
April 26, 2022
Basel, Switzerland
Media release:
English (PDF 0.2 MB) | Deutsch (PDF 0.2 MB) | Français (PDF 0.2 MB)
Interim financial report (PDF 0.4 MB)
Download the presentation (PDF 4.1 MB)
Download the podcast (MP3 40 MB)
Read the presentation transcript
Novartis ESG Update - April 27, 2022 (PDF 0.7 MB)
Reconciliation of 2021 results excluding Roche investment impacts (PDF 0.5 MB)
Disclaimer: The information in the presentations on these pages was factually accurate on the date of publication. These presentations remain on the Novartis website for historical purposes only. Novartis assumes no responsibility to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.